首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal C9orf100 Antibody

  • 中文名: C9orf100抗体
  • 别    名: Rho guanine nucleotide exchange factor 39, ARHGEF39, C9orf100
货号: IPDX33561
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/2000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesRho guanine nucleotide exchange factor 39, ARHGEF39, C9orf100
Entrez GeneID84904
WB Predicted band size38.3kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenThis C9orf100 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 180-211 amino acids from the Central region of human C9orf100.

+ +

参考文献

以下是关于C9orf100抗体的3篇虚构参考文献示例(注:以下内容为模拟生成,实际文献需通过学术数据库查询):

---

1. **文献名称**: "Characterization of C9orf100 Protein Expression in Human Tissues Using a Novel Polyclonal Antibody"

**作者**: Smith A, et al.

**摘要**: 本研究开发了一种针对C9orf100蛋白的多克隆抗体,通过Western blot和免疫组化分析发现,C9orf100在人类脑组织和睾丸中高表达。抗体特异性验证显示其在敲低模型中信号显著降低,提示潜在功能与神经发育相关。

2. **文献名称**: "C9orf100 Interaction with DNA Repair Pathways Revealed by Immunoprecipitation Studies"

**作者**: Lee B, et al.

**摘要**: 利用C9orf100抗体进行免疫共沉淀(Co-IP)实验,发现C9orf100与BRCA1复合物存在相互作用,提示其可能参与DNA损伤修复。抗体在HeLa细胞系中验证有效性,支持其在功能研究中的应用。

3. **文献名称**: "Subcellular Localization of C9orf100 in Cancer Cell Lines: Insights from Immunofluorescence Microscopy"

**作者**: Garcia C, et al.

**摘要**: 通过免疫荧光技术结合C9orf100抗体,研究发现该蛋白主要定位于细胞核及线粒体膜。在不同癌症细胞系中表达差异显著,可能作为肿瘤生物标志物研究的靶点。

---

**提示**:实际研究中请通过PubMed、Google Scholar等平台检索真实文献。若研究较少,可扩展至C9orf100基因的功能分析或相关通路研究,并关注抗体供应商(如Abcam、Thermo Fisher)提供的引用文献列表。

背景信息

The C9orf100 antibody is a research tool designed to target the protein encoded by the C9orf100 gene (Chromosome 9 Open Reading Frame 100), a poorly characterized gene located on human chromosome 9. While the precise biological function of the C9orf100 protein remains unclear, it is hypothesized to play roles in cellular processes such as proliferation, differentiation, or signaling, based on conserved domains or indirect experimental associations. Antibodies against C9orf100 are primarily used in basic research to investigate its expression patterns, subcellular localization, and interactions in various tissues or cell types. These antibodies are often validated in applications like Western blotting, immunohistochemistry (IHC), or immunofluorescence (IF) to map protein distribution under physiological or pathological conditions. Interest in C9orf100 has grown due to genomic studies linking its locus to disease susceptibility regions, though direct evidence of its involvement in specific disorders remains limited. Current research focuses on exploring its potential relevance in cancer, neurodegenerative diseases, or metabolic syndromes using knockout models or overexpression systems. However, the lack of comprehensive functional data and standardized validation protocols for C9orf100 antibodies poses challenges, necessitating careful experimental controls. Commercial C9orf100 antibodies are typically polyclonal or monoclonal reagents raised against peptide antigens derived from predicted epitopes, with validation data varying by supplier. Ongoing studies aim to clarify its molecular interactions and pathways to establish its utility as a biomarker or therapeutic target.

客户数据及评论

折叠内容

大包装询价

×